baber/WOPTO huggingface dataset:
Patent CA-3123529-A1 (CA)
Title: Single phase fault isolation and restoration with loop avoidance
Inventor: KELLER ERICH
IPC: H02J13/00
Filed: 2021-06-28
Abstract: Techniques for controlling a power distribution network are provided. An electronic processor receives, a fault indication associated with a fault from a first isolation device of a plurality of isolation devices. The processor identifies a first subset of a plurality of phases associated with the fault indication and a second subset of the plurality of phases not associated with the fault indication. The processor identifies a downstream isolation device downstream of the fault. The processor sends send a first open command to the downstream isolation device for each phase in the first subset. The processor sends a close command to a tie-in isolation device for each of the plurality of phases. The processor sends a second open command to the downstream isolation device for each phase in the second subset. Responsive to identifying a potential loop configuration, the processor sends the second open command prior to the close command.
Patent CA-3124783-A1 (CA)
Inventor: KAWAGUCHI TAKANORI
IPC: A61K31/529
Filed: 2019-12-24
Abstract: La présente invention concerne : un nouveau composé qui est utile pour traiter ou prévenir des infections associées à des virus appartenant à la sous-famille Pneumovirinae, comprenant le virus respiratoire syncytial (VRS), et qui a une activité anti-VRS ; ou un sel pharmaceutiquement acceptable de celui-ci. Plus spécifiquement, la présente invention concerne : un composé représenté par la formule (I) ou un sel pharmaceutiquement acceptable de celui-ci.
Patent CA-3126006-A1 (CA)
Inventor: LI FENG
IPC: H04L45/16
Filed: 2020-01-07
Abstract: Methods, systems, and computer readable media described herein can be operable to facilitate an IGMP fastleave using a listener reference count. A gateway proxy saves each listener for every specific multicast group, thus the gateway knows if a listener is the last one in the group when it receives a leave report from a listener. The gateway leaves the group immediately without sending specific query if the leave report comes from the last listener of the current group, thereby significantly reducing the leave latency. Otherwise, the standard procedure wins, and the gateway sends out a specific query when the leave report is not from the last listener.
Patent CA-3126429-A1 (CA)
Inventor: SALEEM-UDDIN MOIN AHSON
IPC: C12N15/861
Filed: 2020-01-17
Abstract: La présente invention concerne une thérapie génique à base de vecteur VAA (virus adéno-associé) destinée à être utilisée dans le traitement d'une forme monogénique du syndrome néphrotique, le vecteur VAA comprenant un transgène associé à NS et un promoteur de néphrine minimal NPHS1 ou un promoteur de podocine NPHS2.
Patent CA-3128884-A1 (CA)
Inventor: JORDAN ROBERT B
IPC: B27K3/34
Filed: 2021-08-25
Abstract: An enhanced wood product includes a wooden board or plank having a length and at least three sides, the sides defining a polygonal cross section along the length of the wooden board or plank. A polyurethane-urea coating on at least two of the sides very substantially increases the strength of the wood product and various products made with coated wood.
Patent CA-3130137-A1 (CA)
Inventor: JORDAN PAUL
IPC: C12M1/34
Filed: 2014-03-14
Abstract: Un appareil de couvercle pour un récipient à chambres multiples est décrit. Lappareil de couvercle possède un couvercle supérieur fixé à un chapeau inférieur. Le couvercle supérieur comprend une ou plusieurs ouvertures pour remplir le fluide de multiples passages qui sétendent depuis le chapeau inférieur. Un chapeau inférieur comprend des éléments de soudage pour soudage au récipient à chambres multiples.
Patent CA-3131130-A1 (CA)
Inventor: STANTON MATTHEW G
IPC: C12N15/66
Filed: 2020-03-06
Abstract: Provided herein are compositions and methods for delivering non-viral, capsid-free DNA vectors (ceDNA) to cytosol of a target cell in subject while reducing or inhibiting an immune response.
Patent CA-3132750-A1 (CA)
Inventor: BUSABA FADI
IPC: G06F21/12
Filed: 2020-02-28
Abstract: According to one or more embodiments of the present invention, a computer implemented method includes receiving, by a hypervisor that is executing on a host server, a request to dispatch a virtual machine. The method further includes, based on a determination that the virtual machine is a secure virtual machine, preventing the hypervisor from directly accessing any data of the secure virtual machine by determining, by a secure interface control of the host server, a security mode of the virtual machine. Based on the security mode being a first mode, the secure interface control loads a virtual machine state from a first state descriptor, which is stored in a non-secure portion of memory. Based on the security mode being a second mode, the secure interface control loads the virtual machine state from a second state descriptor, which is stored in a secure portion of the memory.
Patent CA-3135727-A1 (CA)
Inventor: MCCLINCHEY SCOTT
IPC: C12N5/10
Filed: 2021-10-25
Abstract: A novel canola variety designated G00580 and seed, plants and plant parts thereof. Methods for producing a canola plant that comprise crossing canola variety G00580 with another canola plant. Methods for producing a canola plant containing in its genetic material one or more traits introgressed into G00580 through backcross conversion and/or transformation, and to the canola seed, plant and plant part produced thereby. Hybrid canola seed, plant or plant part produced by crossing the canola variety G00580 or a locus conversion of G00580 with another canola variety.
Patent CA-3138437-A1 (CA)
Title: Hybrid utility vehicle
Inventor: BORUD ERIC J
IPC: B62D21/18
Filed: 2017-06-05
Abstract: A vehicle comprises: ground engaging members; a frame; an operator area; and an overhead frame coupled to the frame and configured to move between a raised position and a collapsed position. The overhead frame comprises: a front frame assembly comprising: a first forward frame section pivotably coupled to the vehicle and having a first forward connector portion; and a first rearward frame section having a second forward connector portion configured to releasably attach to the first forward connector portion to lock the front frame assembly in the raised position; and a rear frame assembly comprising: a second forward frame section pivotably connected to the front frame assembly and having a first rear connector portion; and a second rearward frame section having a second rear connector portion configured to releasably attach to the first rear connector portion to lock the rear frame assembly in the raised position.
Patent CA-3141421-A1 (CA)
Inventor: FUJIMOTO TAKESHI
IPC: B22D41/34
Filed: 2020-08-17
Abstract: A technical problern to be solved by the present invention is to, in a sliding nozzle apparatus configured to allow a drive unit to be attached to and detached from a slide metal frame, make it possible to efficiently transmit a driving force of the drive unit to the slide metal frarne. The present invention provides a sliding nozzle apparatus cornprising a connection component 4 attached to a slide metal frame 112 and configured for connection with a drive unit 12, wherein the connection component 4 is provided with an opening with respect to which the drive unit 12 can be attached and detached. The connection cornponent is configured to allow the opening to be switched between a first position where the opening faces in the same direction as an opening-closing direction of the slide metal frame 112, and a second position where the opening faces in the same direction as an attaching-detaching direction of the drive unit 12.
Patent CA-3143382-A1 (CA)
Title: Modified prosthetic heart valve stent
Inventor: PINTOR RAFAEL
IPC: A61F2/24
Filed: 2020-09-24
Abstract: A prosthetic heart valve having an expandable stent modified to reduce the impact on the adjacent conduction system of the heart. A plurality of flexible leaflets arranged to close together along a flow axis through the valve prevent blood flow in one direction, and a support frame surrounds and supports the leaflets. The stent is defined by a plurality of connected struts arranged around a circumference. A pattern of the struts is consistent around the circumference except in a modified region on one side so that when converted to the expanded configuration the stent on the one side expands radially outward a smaller distance and/or has larger cells defined between the struts than around a remainder of the circumference. The stent may be connected to a non- collapsible valve member or the entire valve may be expandable. The valve may be for implant at the aortic annulus and the modified region may be centered at a commissure post of the support frame.
Patent CA-3144773-A1 (CA)
Title: Apparatus and method for thin film deposition
Inventor: MUSSELMAN KEVIN P
IPC: B01J19/26
Filed: 2020-12-18
Abstract: A thin film deposition system including a modular reactor head, a substrate stage and a modular reactor head positioning system. The modular reactor head positioning positions the modular reactor head with respect to the substrate to deliver precursor gases to a substrate located on the substrate stage. The modular reactor head includes a set of modular components that perform different functionalities and may be placed in different configurations.
Patent CA-3147724-A1 (CA)
Title: Heated water availability control
Inventor: CHAUDHRY RAHEEL A
IPC: F24D17/00
Filed: 2020-07-30
Abstract: A water heater system includes a water heater having a first water outlet and a second water outlet. The water heater system further includes a flow detection device coupled to the first water outlet to detect a water flow through the first water outlet. The water heater system also includes a flow control valve fluidly coupled to the second water outlet. The flow control valve is configured to control a flow of water through the second water outlet based on whether the water flow through the first water outlet is detected by the flow detection device.
Patent CA-3148276-A1 (CA)
Title: Vortex tube cooling system and method of using same
Inventor: SINGH AMANJOT
IPC: F25B9/04
Filed: 2020-07-21
Abstract: The present disclosure relates to a vortex tube for separating a working fluid into a first working fluid and a second working fluid, the vortex tube comprising: a hot end; a cold end opposed to the hot end; a vortex generator between the hot end and the cold end, the vortex generator configured to receive a working fluid, the vortex generator comprising: a vortex chamber including a bottom wall defining a bore therethrough; and a plurality of channels configured to direct the working fluid into the vortex chamber, wherein one or more of the bottom wall and the plurality of channels are configured to direct the working fluid in a vortex motion to form a first toroidal moving away from the vortex chamber and towards the hot end; and wherein a first working fluid exits the hot end and a second working fluid is turned away from the hot end and flows through the bore to exit the cold end. The present disclosure also relates to use of the vortex tube for panel and spot cooling.
Patent CA-3150095-A1 (CA)
Title: Engineering of immune cells for ex vivo cell therapy applications
Inventor: O'DEA SHIRLEY
IPC: A61K39/00
Filed: 2020-09-04
Abstract: The invention provides a solution to the problem of transfecting non-adherent cells. Methods and compositions containing ethanol and an isotonic salt solution are used for delivery of compounds and compositions to non-adherent cells, e.g. T cells.
Patent CA-3150927-A1 (CA)
Inventor: ROCHE ELLEN
IPC: A61F2/95
Filed: 2020-09-11
Abstract: L'invention concerne un implant médical (1) qui est adapté pour réparer ou fermer un défaut (D), en particulier une ouverture dans une paroi ventriculaire, auriculaire ou septale (W). L'implant médical (1) peut, en particulier, être un patch. Il comprend une composition adhésive (6). Il comprend en outre deux états, dans le premier état, l'implant médical (1) peut être déployé sur un site d'implant tandis que la composition adhésive (6) est inactive. Il peut être amené dans un second état par un mécanisme d'activation. La composition adhésive (6), dans le second état, est durcissable par un mécanisme de durcissement.
Patent CA-3152824-A1 (CA)
Inventor: ANCIMER RICHARD J
IPC: H01M8/04
Filed: 2020-11-04
Abstract: The subject matter described herein generally relates to a fuel cell power module and air handling system and methods of operating such a system to enable robust exhaust energy extraction for high altitude.
Patent CA-3153305-A1 (CA)
Title: Methods for treating neurological disorders with ?1a-ar partial agonists
Inventor: FORD ANTHONY P
IPC: A61K31/4184
Filed: 2020-10-23
Abstract: In various aspects and embodiments provided are compositions and methods for a disease or disorder in a patient such as a disease or disorder that affects the brain in a patient and treating such patient.
Patent CA-3157582-A1 (CA)
Inventor: ROUND ELLIOTT PAUL EDWARD
IPC: G06T15/50
Filed: 2020-11-06
Abstract: L'invention concerne un procédé de détermination d'une propriété de matériau d'un objet. Le procédé comprend les étapes suivantes : obtention (301) d'une valeur d'intensité de lumière réelle pour chaque position d'un premier nombre de positions de source de lumière et chaque position d'un deuxième nombre de positions de capteur de lumière, la valeur d'intensité de lumière réelle indiquant une intensité de lumière provenant de la position de source de lumière qui est réfléchie ou diffusée par un objet vers la position de capteur de lumière ; détermination (S701) d'une surface tridimensionnelle de l'objet ; et pour chaque point d'une pluralité de points sur la surface tridimensionnelle de l'objet, en utilisant un modèle qui a été entraîné par apprentissage automatique, prédiction (S702) de la propriété de matériau pour l'objet au niveau du point sur la base des valeurs d'intensité de lumière réelle obtenues. La propriété de matériau pour l'objet au niveau du point définit la manière dont la lumière interagit avec l'objet au niveau du point et comprend un ou plusieurs éléments parmi : réflexion spéculaire ; rugosité ; émission de lumière diffuse ; diffusion de sous-surface ; transparence ; et indice de réfraction, et le modèle est un réseau neuronal configuré pour recevoir des valeurs d'intensité de lumière, ainsi que leurs positions de source de lumière et leurs positions de capteur de lumière associées, en tant que couche d'entrée, et pour produire une représentation de la propriété de matériau, en tant que couche de sortie.
Patent CA-3159557-A1 (CA)
Inventor: LEVINSON YONATAN
IPC: A61K35/17
Filed: 2020-11-04
Abstract: La présente invention concerne des procédés de production de lymphocytes T allogéniques, comprenant l'utilisation d'une nucléase modifiée sous le contrôle d'un promoteur re´gulable. En préparant des lymphocytes T avec une nucléase inductible, de grands volumes de cellules peuvent être préparés, chacune desquelles contenant la capacité à produire individuellement la nucléase souhaitée. Ces cellules peuvent ensuite être modifiées selon les besoins par l'introduction d'un gène d'intérêt, ou un gène non souhaité peut être inactivé. L'invention concerne également des lymphocytes T allogéniques destinés à être utilisés dans diverses applications thérapeutiques.
Patent CA-3160028-A1 (CA)
Inventor: ROA BRANDON
IPC: A23C20/00
Filed: 2020-12-10
Abstract: The technology disclosed in this specification pertains to imitations cheese comprising a grade 2 gum Arabic in an amount of from about 0.1% to about 1.0% and having a molecular weight of greater than about 800 kDa. In some embodiments the imitation cheese are low protein imitation cheeses having protein content of less than about 20%. It has been observed that the disclosed cheeses have an improved melt-stretch compared to imitation cheeses made with other hydrocolloids. It has further been observed low protein imitation cheeses comprising a grade 2 gum Arabic have a melt-stretch more like that of a full protein imitation cheese compared to the melt-stretch of imitation cheeses made with other hydrocolloids.
Patent CA-3163410-A1 (CA)
Title: O-phosphoserine export protein variant and method for producing o-phosphoserine, cysteine, and derivatives thereof using the same
Inventor: PARK HYE MIN
IPC: C07K14/00
Filed: 2021-06-08
Abstract: The present application relates to an O-phosphoserine (OPS) export protein variant, and a method for producing O-phosphoserine, cysteine, and cysteine derivatives using the same.
Patent CA-3165960-A1 (CA)
Inventor: KAVETI NAVEEN KUMAR
IPC: G06N20/00
Filed: 2022-06-28
Abstract: Certain aspects of the present disclosure provide techniques for training and using a machine learning model to extract relevant textual content for custom fields in a software application from freeform text samples. An example method generally includes generating, via a natural language processing pipeline, a training data set from a data set of freeform text samples and field entries for a plurality of custom fields defined in a software application. A first machine learning model is trained to identify custom fields for which relevant data is included in freeform text. A second machine learning model is trained to extract content from the freeform text into one or more custom fields of the plurality of custom fields defined in the software application and identified by the first machine learning model as custom fields for which relevant data is included in the freeform text.
Patent CA-3167719-A1 (CA)
Inventor: FONTANEZ KRISTINA
IPC: C12Q1/68
Filed: 2021-01-12
Abstract: Cette divulgation concerne des procédés et des systèmes pour une analyse d'une cellule unique, comprenant une analyse de transcriptome d'une cellule unique, de cellules cibles sans dispositifs microfluidiques. Les procédés divulgués impliquent l'utilisation de particules de matrice pour modéliser la formation de gouttelettes monodispersées pour capturer généralement une cellule cible unique à partir d'une population de cellules dans une encapsulation, dériver une pluralité de molécules d'ARNm distinctes à partir de la cellule cible unique, et quantifier les molécules d'ARNm distinctes pour générer un profil d'expression.
Patent CA-3167740-A1 (CA)
Inventor: BELLOS MICHAEL
IPC: H01S3/04
Filed: 2021-01-13
Abstract: Systems and methods are described for producing an amplitude-modulated laser pulse train. The laser pulse train can be used to cause fluorescence in materials at which the pulse trains are directed. The parameters of the laser pulse train are selected to increase fluorescence relative to a constant-amplitude laser pulse train. The amplitude-modulated laser pulse trains produced using the teachings of this invention can be used to enable detection of specific molecules in applications such as gene or protein sequencing.
Patent CA-3171101-A1 (CA)
Inventor: SCHNEIDER DINA
IPC: C07K14/725
Filed: 2021-06-22
Abstract: Chimeric antigen receptors containing TSLPR-CD19 and TSLPR-CD22 antigen binding domains are disclosed. Nucleic acids, recombinant expression vectors, host cells, antigen binding fragments, and pharmaceutical compositions, relating to the chimeric antigen receptors are also disclosed. Methods of treating or preventing cancer in a subject, and methods of making chimeric antigen receptor T cells are also disclosed.
Patent CA-3171295-A1 (CA)
Title: Systeme de cable
Inventor: AINGER MICHAEL
IPC: H01B3/00
Filed: 2021-03-11
Abstract: L'invention concerne un câble de distribution de puissance et/ou de transmission de données, le câble comprenant une âme comprenant un ou plusieurs conducteurs métalliques et une gaine entourant l'âme, la gaine étant formée à partir d'un polymère ayant un module de traction d'au minimum 1,5 GPa, le diamètre extérieur de la gaine étant au maximum de 13,5 mm et la rigidité du câble étant au minimum de 0,01 Nm2. De manière avantageuse, certains modes de réalisation du câble peuvent faire appel à un soufflage et à une poussée faciles à travers un micro-conduit sans déformation.
Patent CA-3171699-A1 (CA)
Title: Method for identifying microorganisms and/or their resistance to drugs, cartridge and related cartridge panel to perform the method
Inventor: GALIANO PAOLO
IPC: C12Q1/6895
Filed: 2021-03-18
Abstract: Embodiments described here concern a disposable cartridge suitable to carry out molecular biology tests starting from biological samples positive for microorganisms, comprising at least one specific reaction mixture for RT-PCR (Real Time Polymerase Chain Reaction) suitable for typing particular microorganisms and/or for providing information on relative resistance to antimicrobial and antifungal drugs, a panel comprising a plurality of cartridges and a method to identify at least one microorganism and/or its resistance to antimicrobial or antifungal drugs responsible for a systemic inflammatory state.
Patent CA-3173718-A1 (CA)
Inventor: BATTU SERGE
IPC: C12Q1/06
Filed: 2021-04-06
Abstract: La présente invention concerne un procédé de détermination de la résistance d'un microorganisme vis-à-vis d'au moins un antimicrobien à l'aide d'un dispositif de fractionnement par couplage flux-force. Elle comprend également l'utilisation d'un dispositif de fractionnement par couplage flux-force selon ledit procédé, ainsi qu'un kit pour la détermination de la résistance d'un microorganisme vis-à-vis d'au moins un antimicrobien par une technique de fractionnement par couplage flux-force.
Patent CA-3176164-A1 (CA)
Title: Pipelayer machine with rear engine configuration
Inventor: CALDWELL CURTIS J
IPC: B66C23/36
Filed: 2022-09-27
Abstract: A pipelayer machine (100) may comprise a machine chassis (120); an operator cabin (130) supported by the machine chassis (120); an engine (140) supported by the machine chassis (120); and a boom (150) coupled to the machine chassis (120). The operator cabin (130) may include a seat assembly (135). The operator cabin (130) may be stationary with respect to the machine chassis (120). The pipelayer machine (100) may comprise a front portion and a rear portion. The engine (140) may be provided in the rear portion. The boom (150) may be provided forward with respect to the seat assembly (135).
Patent CA-3177512-A1 (CA)
Inventor: BHYRI PRIYANKA
IPC: C12N15/82
Filed: 2012-07-13
Abstract: This invention relates to gene expression regulatory sequences, specifically transcription terminator sequences. Plant transcription terminator sequences are described herein. Methods for identifying novel plant transcription terminator sequences that can terminate transcription in one orientation or in a bidirectional manner and methods of using these terminator sequences to generate transgenic plants are described herein.
Patent CA-3177969-A1 (CA)
Title: Vcp/p97 inhibitor for the treatment of cancer
Inventor: STUART MONIC JAIN
IPC: C07D471/04
Filed: 2021-05-10
Abstract: Described herein are methods of treating cancer in a subject in need thereof comprising administering to the subject a pharmaceutical composition comprising 1-(4-(benzylamino)-5,6,7,8-tetrahydropyrido[2,3-d]pyrimidin-2-yl)-2-methyl-1H-indole-4-carboxamide, or a pharmaceutically acceptable salt thereof, whereby the subject experiences a therapeutic response.
Patent CA-3178397-A1 (CA)
Title: Preserving emergency call during failure to transfer
Inventor: BAKKER JAN HENDRIK LUCAS
IPC: H04W76/50
Filed: 2020-10-09
Abstract: A system and method in a user equipment (UE) for transferring an emergency session from a first network to a second network. The method includes transmitting a first registration request message to the second network; receiving a registration reject message from the second network; detecting the emergency session between the UE and the first network is ongoing; transmitting a second registration request message comprising an emergency registration request to the second network; and receiving a registration accept message for the emergency session.